Robert Accordino - Apr 20, 2022 Form 4 Insider Report for Ontrak, Inc. (OTRK)

Role
Chief Medical Officer
Signature
/s/ Robert Accordino
Stock symbol
OTRK
Transactions as of
Apr 20, 2022
Transactions value $
$0
Form type
4
Date filed
4/22/2022, 04:45 PM
Previous filing
Apr 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTRK Option (right to buy) +Grant/Award +100,000 100,000 Apr 20, 2022 Ontrak, Inc. Common Stock 100,000 $1.74 Direct F1, F2
transaction OTRK Option (right to buy) -Disposed to Issuer -100,000 -100% 0 Apr 20, 2022 Ontrak, Inc. Common Stock 100,000 $10.40 Direct F1, F2

Explanation of Responses:

Id Content
F1 25,000 of these shares shall vest on September 27, 2022 and the remaining shares shall vest equally over the next 36 months, such that all shares shall be vested on September 27, 2025. There was no change to the vesting schedule in connection with the repricing transaction on April 20, 2022.
F2 The reporting person agreed to the repricing of an option granted to him on September 27, 2021.